Page 129 - Journal of Special Operations Medicine - Winter 2014
P. 129

a practical method to guide treatment. Epidemiologic   Table 4  Snakebite Management Guidelines
              awareness and clinical assessment, supplemented by the
              20-minute whole-blood clotting test (20MWBCT; Fig-   •  Notify evacuation authority.
              ure 4) is sufficient to determine  an appropriate treat-  •  Notify medical chain of command.
              ment algorithm.                                      •  Move all suspected envenomation patients to a level of
                                                                     care capable of resuscitation/antivenin administration,
              Figure 4  Twenty-minute whole-blood clotting test.     if indicated.
                                                                   •  Immobilize entire patient and splint affected limb. Do
                                                                     NOT apply a tourniquet.
                                                                   •  If snake has been killed, transport with patient but DO
                                                                     NOT  seek  snake  for  identification.  Be  aware  that  a
                                                                     dead snake is still venomous.
                                                                   •  Initiate cardiopulmonary monitoring and appropri-
                                                                     ate documentation (serial vital signs, mental status/
                                                                     Glasgow Coma Scale score, and clinical signs of
                                                                       envenomation).
                                                                   •  Airway management per standard protocols. Please
                                                                     note that antivenin is unlikely to reverse respiratory
                                                                     paralysis in neurotoxic envenomations, so aggressive
                                                                     airway management should be considered early re-
                                                                     gardless of the availability of antivenin.
                                                                   •  Initiate two large-bore IV lines (IO access if unable to
                                                                     obtain IV).
              The decision to administer antivenin is the crux of ther-  •  Pain management with acetaminophen or opioids (do
              apy; however, administration of antivenin should be    not administer NSAIDs).
              performed in at least a Role 2 facility with appropriate   •  Prepare adjunctive measures for antivenin administration.
              monitoring and emergency  treatment resources avail-      o Advanced airway management (endotracheal intu-
              able. All antivenins carry a risk of anaphylaxis and sub-  bation equipment, LMA, cricothyroidotomy kit)
              sequent  serum  sickness.  Currently  available  antivenin     o IVF (NS or LR)
              has a defined range of therapeutic efficacy and there are     o Epinephrine (or other vasopressor as clinical situa-
              several species for which no antivenin is available (Table   tion dictates)
                                                                          –  Patient with cardiopulmonary compromise may
              3). Antivenin is in short supply, has a limited shelf life,   not respond to IM injection of epinephrine and
              requires dependable cold storage, and is available only    IV epinephrine may be necessary. 1mg of 1:1000
              through a select few manufacturers. Up-to-date infor-      epinephrine can be diluted in 9mL of NS to make
                                             22
              mation on reputable antivenin manufacturers and prod-      1:10,000 solution for IV use. Central line is pre-
              uct availability can be obtained at the websites listed in   ferred, but proximal large-bore IV access can be
              Table 3.                                                   used if emergent.
                                                                        o Antihistamine – diphenhydramine 25–50mg or
              Table 3  Sources for Antivenin Information              equivalent
                                                                        o Antipyretic – acetaminophen or equivalent
              Internet Hyperlinks
                                                                       o Corticosteroid – Solumedrol 125mg IV or equivalent
              www.toxinfo.org/antivenoms/synopsis.html             •  Be aware that resuscitation can lead to increased circu-
              http://globalcrisis.info/latestantivenom.htm           lation of venom from previously underperfused tissue
              http://www.who.int/bloodproducts/animal_sera/en/       and appropriate supportive care precautions should be
              http://www.toxinology.com/                             applied.
              https://intellipedia.intelink.gov/wiki/Antivenom_Resources
                                                                   •  When laboratory services are available, draw pertinent
                                                                     laboratory studies
                                                                        o CBC, electrolytes, glucose, renal function, liver en-
              The criteria for administering antivenin include neuro-  zymes, urinalysis, type and cross, fibrinogen, fibrin
              toxicity, spontaneous systemic bleeding, incoagulable   degradation products, creatinine kinase, PT/PTT
              blood (20MWBCT), cardiovascular instability, exten-     (consider cardiac enzymes if significant cardiopul-
              sive swelling, rapidly progressive swelling, and bites on   monary compromise)
              fingers or toes.  Antivenin is not FDA approved for use   •  Fasciotomy is rarely indicated for snake envenomation.
                          23
              unless waiver authority has been granted through com-  Every effort should be made to document an elevated
                                                                     compartment pressure before deciding to perform a
              mand medical channels and procedures are followed to   fasciotomy.
              administer  the  antivenin  under  IND  protocols.  In  the   •  Empiric antibiotics are not indicated for snakebites.
              event of a suspected envenomation, there are a series
              of administrative and clinical steps to facilitate care of                              (continues)
              the patient (Table 4). Many of these steps should occur



              Clinical Considerations in African Operations                                                  119
   124   125   126   127   128   129   130   131   132   133   134